199 related articles for article (PubMed ID: 8376600)
1. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels.
Tagawa T; Imaizumi T; Endo T; Shiramoto M; Hirooka Y; Ando S; Takeshita A
J Clin Invest; 1993 Sep; 92(3):1483-90. PubMed ID: 8376600
[TBL] [Abstract][Full Text] [Related]
2. V2 receptor-mediated vasodilation in healthy humans.
Tagawa T; Imaizumi T; Shiramoto M; Endo T; Hironaga K; Takeshita A
J Cardiovasc Pharmacol; 1995 Mar; 25(3):387-92. PubMed ID: 7769802
[TBL] [Abstract][Full Text] [Related]
3. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
van Lieburg AF; Knoers NV; Monnens LA; Smits P
J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
[TBL] [Abstract][Full Text] [Related]
4. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
5. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
6. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
Dietz NM; Rivera JM; Warner DO; Joyner MJ
J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
[TBL] [Abstract][Full Text] [Related]
7. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide.
Evora PR; Pearson PJ; Schaff HV
Chest; 1993 Apr; 103(4):1241-5. PubMed ID: 8131474
[TBL] [Abstract][Full Text] [Related]
8. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
Rongen GA; Smits P; Thien T
J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
[TBL] [Abstract][Full Text] [Related]
9. No functional involvement of 5-hydroxytryptamine1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed.
Bruning TA; van Zwieten PA; Blauw GJ; Chang PC
J Cardiovasc Pharmacol; 1994 Sep; 24(3):454-61. PubMed ID: 7528302
[TBL] [Abstract][Full Text] [Related]
10. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in reactive hyperemia in human forearm vessels.
Tagawa T; Imaizumi T; Endo T; Shiramoto M; Harasawa Y; Takeshita A
Circulation; 1994 Nov; 90(5):2285-90. PubMed ID: 7955185
[TBL] [Abstract][Full Text] [Related]
12. Biphasic forearm vascular responses to intraarterial arginine vasopressin.
Suzuki S; Takeshita A; Imaizumi T; Hirooka Y; Yoshida M; Ando S; Nakamura M
J Clin Invest; 1989 Aug; 84(2):427-34. PubMed ID: 2547832
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in exercise-induced vasodilation of the forearm.
Endo T; Imaizumi T; Tagawa T; Shiramoto M; Ando S; Takeshita A
Circulation; 1994 Dec; 90(6):2886-90. PubMed ID: 7994834
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
Hirsch AT; Dzau VJ; Majzoub JA; Creager MA
J Clin Invest; 1989 Aug; 84(2):418-26. PubMed ID: 2527249
[TBL] [Abstract][Full Text] [Related]
16. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
17. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide.
Rudichenko VM; Beierwaltes WH
J Vasc Res; 1995; 32(2):100-5. PubMed ID: 7734655
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide release accounts for insulin's vascular effects in humans.
Scherrer U; Randin D; Vollenweider P; Vollenweider L; Nicod P
J Clin Invest; 1994 Dec; 94(6):2511-5. PubMed ID: 7989610
[TBL] [Abstract][Full Text] [Related]
19. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm.
O'Kane KP; Webb DJ; Collier JG; Vallance PJ
Br J Clin Pharmacol; 1994 Oct; 38(4):311-5. PubMed ID: 7833219
[TBL] [Abstract][Full Text] [Related]
20. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
Fryburg DA
J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
